SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-18-017613
Filing Date
2018-12-20
Accepted
2018-12-20 16:05:38
Documents
3
Period of Report
2019-02-13
Effectiveness Date
2018-12-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a1218_citiuspharma.htm DEF 14A 328616
2 GRAPHIC proxy1.jpg GRAPHIC 286267
3 GRAPHIC proxy2.jpg GRAPHIC 145067
  Complete submission text file 0001213900-18-017613.txt   923895
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 181246280
SIC: 2834 Pharmaceutical Preparations